PT2572193T - Métodos para a examinação de cancro colorretal e pólipos colorretais por medição de metabólitos na urina - Google Patents

Métodos para a examinação de cancro colorretal e pólipos colorretais por medição de metabólitos na urina

Info

Publication number
PT2572193T
PT2572193T PT117828368T PT11782836T PT2572193T PT 2572193 T PT2572193 T PT 2572193T PT 117828368 T PT117828368 T PT 117828368T PT 11782836 T PT11782836 T PT 11782836T PT 2572193 T PT2572193 T PT 2572193T
Authority
PT
Portugal
Prior art keywords
colorectal
metabolites
urine
assessment
measurement
Prior art date
Application number
PT117828368T
Other languages
English (en)
Inventor
Neil Fedorak Richard
Wang Haili
Original Assignee
Univ Alberta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Alberta filed Critical Univ Alberta
Publication of PT2572193T publication Critical patent/PT2572193T/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57419Specifically defined cancers of colon
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483Physical analysis of biological material
    • G01N33/487Physical analysis of biological material of liquid biological material
    • G01N33/493Physical analysis of biological material of liquid biological material urine
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2560/00Chemical aspects of mass spectrometric analysis of biological material
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/06Gastro-intestinal diseases
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/60Complex ways of combining multiple protein biomarkers for diagnosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/24Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PT117828368T 2010-05-21 2011-05-20 Métodos para a examinação de cancro colorretal e pólipos colorretais por medição de metabólitos na urina PT2572193T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34704310P 2010-05-21 2010-05-21

Publications (1)

Publication Number Publication Date
PT2572193T true PT2572193T (pt) 2018-01-31

Family

ID=44991141

Family Applications (1)

Application Number Title Priority Date Filing Date
PT117828368T PT2572193T (pt) 2010-05-21 2011-05-20 Métodos para a examinação de cancro colorretal e pólipos colorretais por medição de metabólitos na urina

Country Status (10)

Country Link
US (2) US10267800B2 (pt)
EP (1) EP2572193B1 (pt)
JP (1) JP5823505B2 (pt)
AU (1) AU2011256064B2 (pt)
CA (2) CA2799757C (pt)
DK (1) DK2572193T3 (pt)
ES (1) ES2656967T3 (pt)
NO (1) NO2572193T3 (pt)
PT (1) PT2572193T (pt)
WO (1) WO2011143779A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9470771B2 (en) 2012-06-08 2016-10-18 Liposcience, Inc. NMR measurements of NMR biomarker GlycA
US9928345B2 (en) 2012-06-08 2018-03-27 Liposciences, Inc. Multiple-marker risk parameters predictive of conversion to diabetes
US9361429B2 (en) 2012-06-08 2016-06-07 Liposcience, Inc. Multi-parameter diabetes risk evaluations
WO2014059025A1 (en) * 2012-10-09 2014-04-17 Liposcience, Inc. Nmr quantification of branched chain amino acids
ES2534732B1 (es) * 2013-08-05 2016-04-21 Servicio Andaluz De Salud Método de clasificación, diagnóstico y seguimiento de individuos con riesgo de padecer cáncer de pulmón mediante el análisis de sudor
WO2015109263A2 (en) 2014-01-17 2015-07-23 University Of Washington Biomarkers for detecting and monitoring colon cancer
US10006925B2 (en) * 2016-05-30 2018-06-26 Universal Diagnostics, S. L. Methods and systems for metabolite and/or lipid-based detection of colorectal cancer and/or adenomatous polyps
JP6779500B2 (ja) 2017-03-30 2020-11-04 株式会社島津製作所 クロマトグラフ質量分析方法及び装置
JP7018605B2 (ja) * 2017-03-30 2022-02-14 株式会社島津製作所 大腸がん検査方法
WO2018184112A1 (en) * 2017-04-05 2018-10-11 Metabolomic Technologies Inc. Methods of high-throughput mass spectrometry based urine test for colorectal states
JP2019105451A (ja) * 2017-12-08 2019-06-27 株式会社日立製作所 尿検体採取時間を登録する尿によるがん検査
US11840720B2 (en) 2019-12-23 2023-12-12 Metabolomic Technologies Inc. Urinary metabolomic biomarkers for detecting colorectal cancer and polyps
KR20230110362A (ko) * 2020-12-07 2023-07-21 킴벌리-클라크 월드와이드, 인크. 대사산물을 검출하기 위한 방법 및 소비자 제품

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6423491B1 (en) * 1998-05-13 2002-07-23 University Of Iowa Research Foundation Method of diagnosing juvenile polyposis (JP)
US7329489B2 (en) 2000-04-14 2008-02-12 Matabolon, Inc. Methods for drug discovery, disease treatment, and diagnosis using metabolomics
ATE555385T1 (de) 2003-03-11 2012-05-15 Crc Inc N1,n12-diacetylspermin als tumormarker
US20080255764A1 (en) 2005-09-12 2008-10-16 Phenomenome Discoveries Inc. Methods for the Diagnosis of Colorectal Cancer and Ovarian Cancer by the Measurement of Vitamin E-Related Metabolites
EP3165925B1 (en) 2005-09-12 2021-09-08 Med-Life Discoveries LP Methods for the diagnosis of colorectal cancer
PT1994410E (pt) * 2006-01-31 2011-01-10 Medical Res Fund Of Tel Aviv Sourasky Medical Ct Métodos e estojos para detecção precoce de cancro ou de predisposição a este
US20090075284A1 (en) 2006-09-19 2009-03-19 The Regents Of The University Of Michigan Metabolomic profiling of prostate cancer
WO2008075663A1 (ja) * 2006-12-21 2008-06-26 Ajinomoto Co., Inc. 大腸癌の評価方法、ならびに大腸癌評価装置、大腸癌評価方法、大腸癌評価システム、大腸癌評価プログラムおよび記録媒体
EP2544006A1 (en) 2007-06-04 2013-01-09 Diagnoplex Biomarker combinations for colorectal cancer
EP2513653A1 (en) * 2009-10-09 2012-10-24 Carolyn Slupsky Methods for diagnosis, treatment and monitoring of patient health using metabolomics
JPWO2011136343A1 (ja) 2010-04-28 2013-07-22 公益財団法人東京都医学総合研究所 がんの検出方法

Also Published As

Publication number Publication date
EP2572193A1 (en) 2013-03-27
JP5823505B2 (ja) 2015-11-25
US11385230B2 (en) 2022-07-12
EP2572193A4 (en) 2013-11-13
CA2799757A1 (en) 2011-11-24
AU2011256064B2 (en) 2016-09-15
CA2799757C (en) 2018-12-04
DK2572193T3 (en) 2018-01-22
CA3025123C (en) 2022-10-11
WO2011143779A1 (en) 2011-11-24
EP2572193B1 (en) 2017-11-01
NO2572193T3 (pt) 2018-03-31
US20190271701A1 (en) 2019-09-05
AU2011256064A1 (en) 2013-01-10
US10267800B2 (en) 2019-04-23
CA3025123A1 (en) 2011-11-24
ES2656967T3 (es) 2018-03-01
US20130065320A1 (en) 2013-03-14
JP2013531226A (ja) 2013-08-01

Similar Documents

Publication Publication Date Title
EP2572193A4 (en) METHODS FOR THE DIAGNOSIS OF COLORECTAL CANCER AND COLORECTAL POLYPES INVOLVING THE ASSAY OF URINARY METABOLITES
EP2617061A4 (en) METHOD AND DEVICE FOR ANALYTIC MEASUREMENT
EP2616556A4 (en) EPIGENETIC MARKERS OF COLORECTAL CANCERS AND DIAGNOSTIC METHODS USING THE SAME
PT2829881T (pt) Diagnóstico para cancro colo-rectal
GB201302520D0 (en) Compositions and methods for detecting cancer metastasis
HK1181895A1 (zh) 用於分析和合成複雜知識表示的系統和方法
EP2542585B8 (en) Methods for treating colorectal cancer
SG2014007454A (en) Pancreatic cancer biomarkers and uses thereof
EP2585833A4 (en) METHODS OF DETECTING CANCER
EP2524233A4 (en) COMPOSITIONS AND METHODS FOR DETECTION OF CANCER
EP2398918A4 (en) COMPOSITIONS AND METHODS FOR THE DIAGNOSIS AND PROGNOSIS OF COLORECTAL CARCINOMA
ZA201300519B (en) Novel antibody for the diagnosis and/or prognosis of cancer
EP2564200B8 (en) Cancer biomarkers and methods of use thereof
EP2625292A4 (en) KREBSBIOMARKER
EP2408465A4 (en) METHOD AND COMPOSITIONS FOR DETECTING CANCER
ZA201302537B (en) Stable and soluble antibodies
EP2596343A4 (en) BIOSENSOR DEVICES AND METHOD THEREFOR
EP2079839A4 (en) ASSESSMENT OF COLORECTAL CARCINOMA RISK
EP2651559A4 (en) METHOD AND DEVICES FOR MEASURING THE CONCENTRATION OF AN ADDITIVE
EP2652507A4 (en) CANCER DETECTION BY ANTI-CCL25 ANTI-CCR9 ANTIBODIES
IL232466A (en) Preparations and Methods for Prostate Cancer Analysis
PL2444811T3 (pl) Sposoby diagnozowania lub prognozowania raka jelita grubego
GB201007711D0 (en) Devices and methods for testing analytes
EP2735571A4 (en) ANTIBODIES FOR DARM CANCER MARKERS
EP2689035A4 (en) METHOD AND KIT FOR THE IN VITRO DETERMINATION OF THE PROBABILITY OF SUFFERING A PATIENT AT A COLORECTAL CARCINOMA